Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

GeneDx Holdings Corp. (WGS) had Revenue of $102.69M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$102.69M
Net Income	$10.81M
Cost of Goods Sold	$31.79M
Gross Profit	$70.90M
Operating Expenses	$93.73M
Operating Income	$8.96M
Non-Operating Income/Expense	$1.60M
Pre-Tax Income	$10.56M
Normalized Pre-Tax Income	$10.56M
Income after Taxes	$10.81M
Income from Continuous Operations	$10.81M
Consolidated Net Income/Loss	$10.81M
Normalized Income after Taxes	$10.81M
EBIT	$8.96M
EBITDA	$15.15M
Weighted-Average Shares Outstanding (Basic)	28.58M
Weighted-Average Shares Outstanding (Diluted)	29.75M
Earnings per Share (EPS) (Basic)	$0.38
Earnings per Share (EPS) (Diluted)	$0.36
Balance Sheet Financials
Current Assets	$204.84M
Property, Plant, and Equipment	$40.12M
Long-Term Assets	$259.03M
Total Assets	$463.86M
Current Liabilities	$71.41M
Long-Term Debt	$51.68M
Long-Term Liabilities	$115.32M
Total Liabilities	$186.73M
Common Equity	$277.13M
Tangible Shareholders Equity	$87.52M
Shareholders Equity	$277.13M
Common Shares Outstanding	28.71M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$20.60M
Cash Flow from Investing Activities	$-45.76M
Cash Flow from Financial Activities	$14.06M
Beginning Cash	$86.20M
End Cash	$75.11M
Increase/Decrease in Cash	$-11.09M
Stock-Based Compensation	$11.80M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.87
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.16
Debt to Equity Ratio	0.19
Gross Margin	69.04%
Operating Margin	8.73%
EBIT Margin	8.73%
EBITDA Margin	--
Pre-Tax Profit Margin	10.29%
Profit Margin	10.53%
Free Cash Flow	$12.10M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.22
Inventory Turnover	2.66
Receiveable Turnover	2.14
Days Sales in Receivables	42.09
Return on Equity	3.90%
Return on Tangible Equity	12.35%
Return on Assets	2.33%
Return on Investments	3.29%
Book Value Per Share	$9.65
Free Cash Flow per Share	$0.41
Operating Cash Flow per Share	$0.69

Data from Zacks Investment Research, Inc.